In a nutshell This study evaluated the effect of 3-dimensional (3D) digital models to plan robotic-assisted laparoscopic radical prostatectomy (RALP) on the outcomes of patients with prostate cancer (PCa). The data showed that 3D digital models significantly improved the outcomes of these patients. Some background PCa is one of the most...
Read More
In a nutshell This study evaluated the effectiveness and safety of prostate artery embolization (PAE) compared to dutasteride (Avodart) and tamsulosin (Flomax) as the first alternative treatment for benign prostatic hyperplasia (BPH) in patients who had not received previous treatment. The study found that PAE was more effective than medical...
Read More
In a nutshell This study evaluated the long-term effectiveness and safety of desmopressin (Minirin Melt®) treatment in older people with nocturia. The research found that this treatment was well-tolerated in the long term in these patients. Some background Older people often wake up during the night to urinate (nocturia)....
Read More
In a nutshell This study evaluated the real-world experiences of patients treated with endoscopic enucleation of the prostate (EEP) with the solid-state Thulium laser system (Thulio) for benign prostatic hyperplasia (BPH) treatment. The studies concluded that Thulium laser EEP was a safe and effective treatment option for these...
Read More
In a nutshell This study investigated whether adding docetaxel (Taxotere) chemotherapy to standard hormonal therapy (HT) before radical prostatectomy (RP – prostate-removal surgery) improved the survival of men with locally advanced prostate cancer (PCa) compared to hormonal therapy alone. It concluded that the addition of...
Read More
In a nutshell This study evaluated whether the Vigor 2020, a new vacuum erection device (VED), is effective for the management of erectile dysfunction (ED). The main finding was that Vigor 2020 was effective for men with ED. Some background Erectile dysfunction (ED) is the inability to get or keep an erection firm enough to...
Read More
In a nutshell This study aimed to evaluate the effectiveness and safety of transperineal laser ablation (TPLA) of the prostate for patients with lower urinary tract symptoms (LUTS) due to an enlarged prostate. The data showed that TPLA was effective and safe for these patients. Some background Lower urinary tract symptoms (LUTS) such as urination...
Read More
In a nutshell This study evaluated the effectiveness and safety of giving a double dose of tamsulosin (Flomax; 0.8 mg per day) to patients with benign prostatic hyperplasia (BPH) who did not respond to the standard tamsulosin dose (0.4 mg per day) and who could not have prostate surgery. The data showed that a double dose of tamsulosin was an...
Read More
In a nutshell This study reviewed the effectiveness and safety of L-arginine and Pycnogenol® (PAL) in the treatment of male erectile dysfunction (ED). The data showed that the combination of PAL had a significant effect on improving sexual function in patients with mild to moderate ED. Some background Erectile dysfunction (ED) is the persistent...
Read More
In a nutshell This study evaluated the effectiveness of holmium laser enucleation of the median lobe of the prostate (HoLEP) on preserving sexual and urinary function in patients with benign prostatic hyperplasia (BPH). The data showed that HoLEP significantly improved urinary function with preservation of ejaculation (sexual function) in these...
Read More
In a nutshell This study evaluated the effectiveness and safety of salvage radiotherapy (RT) combined with hormone therapy in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP; prostate removal surgery). This study found that salvage RT combined with hormone therapy was more effective than salvage RT...
Read More
In a nutshell This study reported the long-term effectiveness and safety of enzalutamide (Xtandi) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that enzalutamide in combination with ADT improved the overall survival over the long term with...
Read More
